236 related articles for article (PubMed ID: 31705897)
1. Spatiotemporal distribution of chondroitin sulfate proteoglycans after optic nerve injury in rodents.
Pearson CS; Solano AG; Tilve SM; Mencio CP; Martin KR; Geller HM
Exp Eye Res; 2020 Jan; 190():107859. PubMed ID: 31705897
[TBL] [Abstract][Full Text] [Related]
2. The chondroitin sulfate proteoglycans neurocan, brevican, phosphacan, and versican are differentially regulated following spinal cord injury.
Jones LL; Margolis RU; Tuszynski MH
Exp Neurol; 2003 Aug; 182(2):399-411. PubMed ID: 12895450
[TBL] [Abstract][Full Text] [Related]
3. Limited growth of severed CNS axons after treatment of adult rat brain with hyaluronidase.
Moon LD; Asher RA; Fawcett JW
J Neurosci Res; 2003 Jan; 71(1):23-37. PubMed ID: 12478611
[TBL] [Abstract][Full Text] [Related]
4. NG2 and phosphacan are present in the astroglial scar after human traumatic spinal cord injury.
Buss A; Pech K; Kakulas BA; Martin D; Schoenen J; Noth J; Brook GA
BMC Neurol; 2009 Jul; 9():32. PubMed ID: 19604403
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive atlas of Aggrecan, Versican, Neurocan and Phosphacan expression across time in wildtype retina and in retinal degeneration.
Matsuyama A; Kalargyrou AA; Smith AJ; Ali RR; Pearson RA
Sci Rep; 2022 May; 12(1):7282. PubMed ID: 35508614
[TBL] [Abstract][Full Text] [Related]
6. Changes in distribution, cell associations, and protein expression levels of NG2, neurocan, phosphacan, brevican, versican V2, and tenascin-C during acute to chronic maturation of spinal cord scar tissue.
Tang X; Davies JE; Davies SJ
J Neurosci Res; 2003 Feb; 71(3):427-44. PubMed ID: 12526031
[TBL] [Abstract][Full Text] [Related]
7. Ischemic injury leads to extracellular matrix alterations in retina and optic nerve.
Reinhard J; Renner M; Wiemann S; Shakoor DA; Stute G; Dick HB; Faissner A; Joachim SC
Sci Rep; 2017 Mar; 7():43470. PubMed ID: 28262779
[TBL] [Abstract][Full Text] [Related]
8. Composition of perineuronal net extracellular matrix in rat brain: a different disaccharide composition for the net-associated proteoglycans.
Deepa SS; Carulli D; Galtrey C; Rhodes K; Fukuda J; Mikami T; Sugahara K; Fawcett JW
J Biol Chem; 2006 Jun; 281(26):17789-800. PubMed ID: 16644727
[TBL] [Abstract][Full Text] [Related]
9. The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.
McKeon RJ; Jurynec MJ; Buck CR
J Neurosci; 1999 Dec; 19(24):10778-88. PubMed ID: 10594061
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes of aggrecan, versican and neurocan in the retina and optic nerve.
Popp S; Maurel P; Andersen JS; Margolis RU
Exp Eye Res; 2004 Sep; 79(3):351-6. PubMed ID: 15336497
[TBL] [Abstract][Full Text] [Related]
11. Decorin suppresses neurocan, brevican, phosphacan and NG2 expression and promotes axon growth across adult rat spinal cord injuries.
Davies JE; Tang X; Denning JW; Archibald SJ; Davies SJ
Eur J Neurosci; 2004 Mar; 19(5):1226-42. PubMed ID: 15016081
[TBL] [Abstract][Full Text] [Related]
12. Isolation of a tenascin-R binding protein from mouse brain membranes. A phosphacan-related chondroitin sulfate proteoglycan.
Xiao ZC; Bartsch U; Margolis RK; Rougon G; Montag D; Schachner M
J Biol Chem; 1997 Dec; 272(51):32092-101. PubMed ID: 9405406
[TBL] [Abstract][Full Text] [Related]
13. Identification of a critical sulfation in chondroitin that inhibits axonal regeneration.
Pearson CS; Mencio CP; Barber AC; Martin KR; Geller HM
Elife; 2018 May; 7():. PubMed ID: 29762123
[TBL] [Abstract][Full Text] [Related]
14. The endogenous proteoglycan-degrading enzyme ADAMTS-4 promotes functional recovery after spinal cord injury.
Tauchi R; Imagama S; Natori T; Ohgomori T; Muramoto A; Shinjo R; Matsuyama Y; Ishiguro N; Kadomatsu K
J Neuroinflammation; 2012 Mar; 9():53. PubMed ID: 22420304
[TBL] [Abstract][Full Text] [Related]
15. Axonal regeneration through regions of chondroitin sulfate proteoglycan deposition after spinal cord injury: a balance of permissiveness and inhibition.
Jones LL; Sajed D; Tuszynski MH
J Neurosci; 2003 Oct; 23(28):9276-88. PubMed ID: 14561854
[TBL] [Abstract][Full Text] [Related]
16. ADAMTS4 and ADAMTS5 knockout mice are protected from versican but not aggrecan or brevican proteolysis during spinal cord injury.
Demircan K; Topcu V; Takigawa T; Akyol S; Yonezawa T; Ozturk G; Ugurcu V; Hasgul R; Yigitoglu MR; Akyol O; McCulloch DR; Hirohata S
Biomed Res Int; 2014; 2014():693746. PubMed ID: 25101296
[TBL] [Abstract][Full Text] [Related]
17. Alterations in sulfated chondroitin glycosaminoglycans following controlled cortical impact injury in mice.
Yi JH; Katagiri Y; Susarla B; Figge D; Symes AJ; Geller HM
J Comp Neurol; 2012 Oct; 520(15):3295-313. PubMed ID: 22628090
[TBL] [Abstract][Full Text] [Related]
18. Lesion-induced differential expression and cell association of Neurocan, Brevican, Versican V1 and V2 in the mouse dorsal root entry zone.
Beggah AT; Dours-Zimmermann MT; Barras FM; Brosius A; Zimmermann DR; Zurn AD
Neuroscience; 2005; 133(3):749-62. PubMed ID: 15896911
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate proteoglycans inhibit oligodendrocyte myelination through PTPĪ.
Pendleton JC; Shamblott MJ; Gary DS; Belegu V; Hurtado A; Malone ML; McDonald JW
Exp Neurol; 2013 Sep; 247():113-21. PubMed ID: 23588220
[TBL] [Abstract][Full Text] [Related]
20. Chondroitin sulfate and chondroitin/keratan sulfate proteoglycans of nervous tissue: developmental changes of neurocan and phosphacan.
Meyer-Puttlitz B; Milev P; Junker E; Zimmer I; Margolis RU; Margolis RK
J Neurochem; 1995 Nov; 65(5):2327-37. PubMed ID: 7595522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
